Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade

The success of immune checkpoint receptor blockade has brought exciting promises for the treatment of head and neck squamous cell carcinoma (HNSCC). While patients who respond to checkpoint inhibitors tend to develop a durable response, <15% of patients with HNSCC respond to immune checkpoint inh...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Dent Res
Asıl Yazarlar: Heath, B.R., Michmerhuizen, N.L., Donnelly, C.R., Sansanaphongpricha, K., Sun, D., Brenner, J.C., Lei, Y.L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2019
Konular:
Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6704427/
https://ncbi.nlm.nih.gov/pubmed/31340724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034519864112
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller